Compare Stocks

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AUP Aurinia Pharmaceuticals		C$16.76	C$11.77 ▼ C$26.00	C$2.15B	N/A	229,895 shs	4.61 million shs
CMG Chipotle Mexican Grill	$2,870.07 -1.3%	$2,783.24	$1,768.64 ▼ $3,023.98	$78.70B	1.28	234,112 shs	441,773 shs
EMIS Emisphere Technologies	$7.81	$7.81	$4.06 ▼ $9.16	N/A	N/A	N/A	N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AUP Aurinia Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
CMG Chipotle Mexican Grill	-1.30%	-2.97%	-0.80%	+22.94%	+59.01%
EMIS Emisphere Technologies	0.00%	0.00%	0.00%	0.00%	0.00%

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CMG Chipotle Mexican Grill	4.0513 of 5 stars	2.3	3.0	0.0	2.0	3.7	2.5	2.5
EMIS Emisphere Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A
CMG Chipotle Mexican Grill	2.64	Moderate Buy	$2,759.14	-3.86% Downside
EMIS Emisphere Technologies	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest AUP, IRE, GBG, CMG, and EMIS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/18/2024	CMG Chipotle Mexican Grill	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$2,900.00 ➝ $3,200.00
4/16/2024	CMG Chipotle Mexican Grill	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$2,350.00 ➝ $2,700.00
4/12/2024	CMG Chipotle Mexican Grill	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$2,500.00 ➝ $2,986.00
4/12/2024	CMG Chipotle Mexican Grill	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$3,010.00
4/11/2024	CMG Chipotle Mexican Grill	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2,900.00 ➝ $3,400.00
4/11/2024	CMG Chipotle Mexican Grill	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2,700.00 ➝ $3,270.00
4/10/2024	CMG Chipotle Mexican Grill	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$2,900.00
4/9/2024	CMG Chipotle Mexican Grill	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$2,750.00 ➝ $3,250.00
4/8/2024	CMG Chipotle Mexican Grill	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$3,016.00 ➝ $3,358.00
4/4/2024	CMG Chipotle Mexican Grill	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$3,265.00 ➝ $3,366.00

(Data available from 4/20/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AUP Aurinia Pharmaceuticals	C$57.59M	0.00	N/A	6.75	C$2.59 per share	0.00
CMG Chipotle Mexican Grill	$9.87B	7.97	$56.29 per share	50.99	$111.58 per share	25.72
EMIS Emisphere Technologies	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AUP Aurinia Pharmaceuticals	N/A	-C$1.48	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CMG Chipotle Mexican Grill	$1.23B	$44.35	64.71	44.29	2.46	12.45%	44.41%	16.27%	4/24/2024 (Confirmed)
EMIS Emisphere Technologies	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest AUP, IRE, GBG, CMG, and EMIS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/24/2024	N/A	CMG Chipotle Mexican Grill	$11.34	N/A	-$11.34	N/A	N/A	N/A
2/6/2024	Q4 2023	CMG Chipotle Mexican Grill	$9.73	$10.36	+$0.63	$10.51	$2.49 billion	$2.52 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
CMG Chipotle Mexican Grill	N/A	N/A	N/A	N/A	N/A
EMIS Emisphere Technologies	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AUP Aurinia Pharmaceuticals	2.69	11.93	11.02
CMG Chipotle Mexican Grill	N/A	1.57	1.53
EMIS Emisphere Technologies	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
AUP Aurinia Pharmaceuticals	N/A
CMG Chipotle Mexican Grill	91.31%
EMIS Emisphere Technologies	N/A

Insider Ownership

Company	Insider Ownership
AUP Aurinia Pharmaceuticals	N/A
CMG Chipotle Mexican Grill	0.96%
EMIS Emisphere Technologies	72.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AUP Aurinia Pharmaceuticals	294	128.40 million	N/A	Not Optionable
CMG Chipotle Mexican Grill	116,068	27.42 million	27.16 million	Optionable
EMIS Emisphere Technologies	6	N/A	N/A	Not Optionable

AUP, IRE, GBG, CMG, and EMIS Headlines

Source	Headline
	Global Microbial Therapeutic Products Industry Is Expected to Reach US$30.55 Billion at a 7.5% CAGR by 2030 \| FMI fmiblog.com - April 9 at 2:00 PM
	Exco Technologies Limited (XTC.TO) ca.finance.yahoo.com - March 3 at 2:53 PM
	Global Microbial Therapeutic Products Industry Poised for 7.5% CAGR, Eyeing US$ 30.55 Billion Valuation by 2030 \| FMI Insights pharmiweb.com - December 21 at 2:04 PM
	Insulin pill could free diabetics from jabs dailymail.co.uk - December 11 at 8:35 AM
	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Emisphere Technologies, Inc. with Losses of $100,000 to Contact the Firm barrons.com - November 19 at 2:57 PM
	Global Microbial Therapeutic Products Industry to Surpass US$ 30 Billion by 2030, Exhibiting 7.5% Growth \| FMI Report pharmiweb.com - November 8 at 3:16 PM
	EMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Emisphere Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! businesswire.com - October 23 at 8:34 PM
	Class Action Complaint Filed Against Emisphere Technologies, Inc. jdjournal.com - October 6 at 1:06 PM
	Entwistle & Cappucci LLP Files a Securities Class Action Complaint Against Emisphere Technologies, Inc. benzinga.com - October 5 at 8:24 PM
	Microbial Therapeutic Products Market Anticipates 7.5% CAGR, Envisioning a US$ 30.55 Billion Industry by 2030 \| FMI pharmiweb.com - August 25 at 4:56 PM
	Lionsgate Chairman Rachesky Loses Bid to End Emisphere Deal Case news.bloomberglaw.com - August 3 at 8:53 PM
	Microbial Therapeutic Products Market is projected to register 7.5% CAGR and reach a valuation of US$ 30.55 Billion by of 2030 fmiblog.com - June 12 at 3:04 PM
	Buccal Drug Delivery System Global Market Report 2023 finance.yahoo.com - May 8 at 12:41 PM
	Flying high on obesity success, Novo's appetite for partnerships grows health.economictimes.indiatimes.com - May 5 at 5:15 AM
	Flying high on obesity success, Novo's appetite for deals grows msn.com - May 4 at 1:37 PM
	Informative Market Research Report on Thrombin Inhibitor with Estimated CAGR of 12.5% from 2023-2030 marketwatch.com - April 16 at 8:50 AM
	Microbial Therapeutic Products Market is anticipated to attain a valuation of US$ 30.55 Billion by 2030 at a high CAGR of 7.5% fmiblog.com - April 14 at 3:19 AM
	Oral Biologics & Biosimilars Global Market Report 2023 uk.finance.yahoo.com - April 11 at 2:26 PM
	Incretin-Based Drugs Market Size Regional Analysis 2023 which includes Rapid Growth Rate Till 2025 marketwatch.com - March 2 at 7:39 AM
	Global Non-insulin Diabetes Therapeutics Market Size Analysis, Share, Application, Opportunities Forecast to 2030 By VMReports marketwatch.com - February 19 at 10:18 AM
	Insulin Detemir Market 2023 Size, Share, Applications, Advance Technology And Top Companies To 2026 marketwatch.com - February 14 at 6:15 PM
	Microbial Therapeutic Products Market Future Scenarios, Growth and Analytical Insights – 2030 fmiblog.com - September 26 at 3:59 PM
	Global Pernicious Anemia Market Report 2022-2028: Increasing Prevalence of Autoimmune Conditions Driving Sector Growth - ResearchAndMarkets.com finance.dailyherald.com - September 26 at 10:58 AM
	Oral Biologics & Biosimilars Global Market Report 2022 benzinga.com - September 23 at 1:28 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
April 2, 2024 11:07 AM
View Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
4 Overbought Household Names, Time for a Pullback?
March 25, 2024 9:35 AM
View 4 Overbought Household Names, Time for a Pullback?
How and When to Roll Your Options Positions?
March 27, 2024 9:32 AM
View How and When to Roll Your Options Positions?
You Can Follow BlackRock’s Market View for Your Money
April 12, 2024 10:00 AM
View You Can Follow BlackRock’s Market View for Your Money

All Headlines

Company Descriptions

Aurinia Pharmaceuticals

TSE:AUP

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Chipotle Mexican Grill

NYSE:CMG

Chipotle Mexican Grill, Inc., together with its subsidiaries, owns and operates Chipotle Mexican Grill restaurants. It sells food and beverages through offering burritos, burrito bowls, quesadillas, tacos, and salads. The company also provides delivery and related services its app and website. It has operations in the United States, Canada, France, Germany, and the United Kingdom. Chipotle Mexican Grill, Inc. was founded in 1993 and is headquartered in Newport Beach, California.

Emisphere Technologies

OTCMKTS:EMIS

Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial